Moreover, one patient in the MTM group was on mixed insulin and was switched to aspart and glargine insulin to improve nocturnal hypoglycaemia; however, the number of insulin medications increased from 16 at the study entry to 17 at the end of the follow-up period. The gene discussed is INS; the disease is Hypoglycemia.